Chonluten, Tripeptide, EDG peptide, Peptide bioregulator, Glu-Asp-Gly, Research reagent, High purity peptide, Respiratory tissue peptide

WhatsApp +852 9339 8574
Chonluten is a synthetic short-chain tripeptide. As a popular research-grade peptide, it has garnered sustained attention in fundamental peptide research due to its stable molecular structure and well-defined regulatory activity at the cellular level. Produced using established solid-phase synthesis technology, the product achieves high purity and consistent batch quality. It is supplied with comprehensive quality control documentation, meeting the needs of various laboratories for sample testing and research projects. In the field of peptide bioactivity research, Chonluten is primarily used in experiments focusing on the maintenance of epithelial cell homeostasis, the regulation of oxidative stress, and the balance of the cellular microenvironment; it serves as a common short-peptide research tool in fundamental studies of tissues and cells.

Chonluten’s molecular structure consists of three amino acid units—glutamic acid, aspartic acid, and glycine—linked together. Its short-chain configuration imparts excellent solubility, making it compatible with the solvent environments of diverse experimental systems; this allows researchers to easily prepare samples at various concentrations for *in vitro* cell model studies. Solid-phase peptide synthesis is the core production method; following synthesis, the product undergoes multiple rounds of chromatographic purification, drying, and sieving to remove impurities, truncated peptide fragments, and residual solvents generated during the process. The final product is a white powder with stable physicochemical properties; under appropriate storage conditions, it maintains molecular structural integrity over the long term, thereby minimizing the risk of activity loss. Each batch undergoes qualitative and quantitative analysis—including High-Performance Liquid Chromatography (HPLC) and mass spectrometry—and is issued a Certificate of Analysis (COA). This report documents parameters such as purity, moisture content, and impurity levels, ensuring batch-to-batch consistency, reducing data deviations caused by experimental variables, and facilitating the reproducibility of research projects.

In cellular research, the primary focus of Chonluten studies is the regulation of homeostasis in respiratory epithelial cells. As a cellular barrier, epithelial tissue is constantly exposed to external environmental stimuli and is prone to the accumulation of oxidative metabolic byproducts; this can trigger intracellular oxidative imbalance, thereby disrupting normal cellular metabolic processes. Existing in vitro data indicate that Chonluten acts on epithelial cells by modulating intracellular oxidative metabolic pathways; it helps clear excess oxidative metabolites, mitigates oxidative damage, and maintains the dynamic balance between intracellular oxidation and antioxidant systems. When cells are subjected to stress from external stimuli, they release various signaling factors that disrupt the local environment. Chonluten modulates the expression levels of these factors, thereby tempering excessive stress responses, preserving the structural integrity of epithelial cells, and maintaining stable barrier function.

Beyond its fundamental antioxidant and stress-regulatory roles, research on Chonluten also encompasses cellular metabolism and cell cycle dynamics. Under sustained external stress, epithelial cell proliferation and metabolic rhythms can become disordered, impairing the normal turnover of cell populations. Relevant in vitro studies demonstrate that Chonluten participates in cell signaling processes, positively regulating growth and metabolic rhythms; this helps maintain a stable turnover cycle and reduces the occurrence of abnormal metabolic states. The peptide does not indiscriminately interfere with all cellular activities but exhibits a degree of targeting preference, acting primarily on respiratory tract epithelial cells. This characteristic makes it a preferred research agent for investigating the mechanisms of interaction between short peptides and epithelial tissues.

In terms of research applications, Chonluten is primarily utilized in the basic experimental platforms of universities, research institutes, and biotechnology R&D companies. A major application area is the study of mechanisms underlying the respiratory epithelial barrier; researchers use in vitro cell culture models to observe the peptide's impact on barrier integrity and explore how it regulates the cellular environment, thereby providing empirical data for fundamental research on epithelial cell protection. Additionally, it is used in oxidative stress models: following the induction of oxidative damage, Chonluten is administered to observe changes in parameters such as cell viability and antioxidant levels, allowing for the assessment of its cytoprotective effects and the screening of antioxidant peptide activity. This raw material is also suitable for exploring the structure-activity relationships of peptide molecules. As a tripeptide bioregulator, it enables the study of the link between amino acid sequence alterations and biological activity, facilitates the comparison of action modes among different short-chain peptides at the cellular level, and enriches the body of research material regarding fundamental peptide theory.

Chonluten possesses unique characteristics compared to other short-chain peptide raw materials. While many similar short-chain bioregulatory peptides target other tissue types, research into Chonluten’s biological activity has focused primarily on the respiratory epithelial system, resulting in a substantial body of experimental literature in this specific area. Compared to long-chain peptides, tripeptides feature a simpler molecular structure; they are easier to synthesize, impurities are more readily removed to achieve higher purity, and they offer greater molecular stability. They are convenient to dissolve and highly compatible with experimental systems, avoiding common issues associated with large-molecule peptides—such as aggregation or precipitation—thereby facilitating controlled experiments across various concentration gradients. It should be noted that Chonluten is intended solely as a raw material for scientific research; all descriptions of its activity are based on findings from *in vitro* cell studies, and the product is restricted to laboratory research use only.

Storage conditions directly impact the quality and stability of Chonluten powder. It is recommended to store the product in a sealed container at low temperatures and away from light—ideally in a freezer—to avoid prolonged storage at room temperature. When sampling, minimize the time the container remains open to prevent atmospheric moisture or impurities from contaminating the powder, which could lead to hygroscopic absorption or molecular degradation. Aliquoting should ideally be performed in a dry, inert gas environment to reduce the risk of oxidation. When stored under these recommended conditions, the product maintains stable physicochemical properties over the long term, ensuring the reliability of subsequent experimental results.

Regarding supply chain and availability, this raw material is offered in a range of packaging specifications—from small-scale research samples to bulk quantities—to meet the diverse procurement needs of both pilot studies and large-scale experimental projects. The supply process is well-established; following order confirmation, quality inspection and shipment are arranged promptly. Comprehensive documentation, including batch-specific Certificates of Analysis (CoA) and physicochemical data, is provided to facilitate incoming quality verification and the filing of experimental protocols by the purchaser. We can accommodate client needs by providing samples from different batches for preliminary activity assays, enabling early verification of sample quality and reducing the costs associated with trial-and-error in large-scale procurement.

As peptide research advances, short-chain bioregulatory peptides are garnering increasing attention from the scientific community. Chonluten, a tripeptide with potential for research into the regulation of respiratory epithelial cells, offers numerous avenues for further investigation. Extensive *in vitro* cell studies have already demonstrated its observable biological activity in areas such as antioxidation, the regulation of cellular stress responses, and the maintenance of epithelial barrier integrity. Future research could expand into co-culture models and multi-factor combined stimulation assays to further elucidate the molecule's mechanisms of action. As a high-purity peptide reagent for research, Chonluten serves as a reliable material for fundamental studies in fields such as epithelial cell biology, redox biology, and peptide structure-activity relationships; it is a short-peptide product seeing steadily rising interest within its specific niche of the global market for research-grade peptides.